Michael J. Fox Foundation ·
Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Nuclear Receptors and Signaling, and Neuroinflammation and Neurodegeneration Mechanisms.
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging
<i>LRRK2</i> -associated parkinsonism with and without <i>in vivo</i> evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
A proteogenomic view of Parkinson’s disease causality and heterogeneity
Deep Learning for Daily Monitoring of Parkinson’s Disease Outside the Clinic Using Wearable Sensors
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
Differences in the Presentation and Progression of Parkinson's Disease by Sex
Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)
The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
Finding useful biomarkers for Parkinson’s disease
Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features
Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s disease
CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort
Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease